2024
Trends in use of intensive care during hospitalizations at the end‐of‐life among older adults with advanced cancer
Jain S, Long J, Rao V, Law A, Walkey A, Prsic E, Lindenauer P, Krumholz H, Gross C. Trends in use of intensive care during hospitalizations at the end‐of‐life among older adults with advanced cancer. Journal Of The American Geriatrics Society 2024 PMID: 39090970, DOI: 10.1111/jgs.19119.Peer-Reviewed Original ResearchEnd-of-life hospitalizationsLife-sustaining treatmentEnd-of-lifeIntensity of careIn-hospital deathOlder adultsIntensive care unitAdvanced cancerRisk-adjusted hospitalEvaluate trendsIncreased intensity of careIntensive care unit useSEER-Medicare dataIntensive care unit careMultinomial regression modelsYear of diagnosisIntensive careHospital categoryMedicare beneficiariesSEER-MedicareHospitalization ratesCareCancer characteristicsNoninvasive ventilationHospital
2022
End-of-life care trajectories among older adults with lung cancer
Davidoff AJ, Canavan ME, Prsic E, Saphire M, Wang SY, Presley CJ. End-of-life care trajectories among older adults with lung cancer. Journal Of Geriatric Oncology 2022, 14: 101381. PMID: 36202695, PMCID: PMC9974538, DOI: 10.1016/j.jgo.2022.09.010.Peer-Reviewed Original ResearchConceptsCancer-directed therapyLung cancerCare trajectoriesOlder adultsSupportive care servicesSEER-Medicare dataSkilled nursing facilitiesNon-Hispanic whitesRace/ethnicityCancer decedentsSymptom managementIntensive careOlder decedentsConcurrent careHospice careReferral regionsHigh riskMultinomial logistic regressionNursing facilitiesMedicare decedentsCare servicesLogistic regressionCancerHospiceDecedents
2020
The association between initial chemotherapy treatment timing, intensity, and end-of-life (EOL) care trajectory among older adults with advanced stage lung cancer (aLC).
Presley C, Shahzad H, Canavan M, Prsic E, Saphire M, Wang S, Davidoff A. The association between initial chemotherapy treatment timing, intensity, and end-of-life (EOL) care trajectory among older adults with advanced stage lung cancer (aLC). Journal Of Clinical Oncology 2020, 38: e24009-e24009. DOI: 10.1200/jco.2020.38.15_suppl.e24009.Peer-Reviewed Original ResearchAdvanced-stage lung cancerDoublet chemotherapyEOL groupOlder adultsIntensity groupInitial chemotherapy regimenInitial chemotherapy treatmentPlatinum-based doubletsPlatinum-doublet chemotherapyFirst-line therapyUse of chemotherapyMajority of patientsEOL care preferencesStage lung cancerMain outcome measuresNon-Hispanic whitesMedicare registryChemotherapy regimenLine therapyCisplatin chemotherapyLung cancerChemotherapy treatmentAge 66Outcome measuresCare trajectories
2019
Patterns of Symptom Management Medication Receipt at End-of-Life Among Medicare Beneficiaries With Lung Cancer
Saphire ML, Prsic E, Canavan ME, Wang SJ, Presley CJ, Davidoff AJ. Patterns of Symptom Management Medication Receipt at End-of-Life Among Medicare Beneficiaries With Lung Cancer. Journal Of Pain And Symptom Management 2019, 59: 767-777.e1. PMID: 31778783, PMCID: PMC7338983, DOI: 10.1016/j.jpainsymman.2019.11.015.Peer-Reviewed Original ResearchConceptsNausea/vomitingMedication receiptEnd of lifeLung cancerOutpatient settingOlder adultsEnd Results-Medicare databaseEmotional distressPoor patient-provider communicationReceipt of medicationSymptom management medicationsHigh symptom burdenAge 67 yearsPatient demographic characteristicsMultivariable logistic regressionPatient-provider communicationMedicare hospice benefitOutpatient medicationsConcurrent therapyRetrospective cohortSymptom burdenSymptomatic managementHospice enrollmentSymptom managementD claimsPatterns of palliative symptom management (PSM) medication use at end-of-life (EoL) among Medicare beneficiaries with advanced lung cancer (advLC).
Davidoff A, Prsic E, Saphire M, Canavan M, Wang S, McCorkle R, Presley C. Patterns of palliative symptom management (PSM) medication use at end-of-life (EoL) among Medicare beneficiaries with advanced lung cancer (advLC). Journal Of Clinical Oncology 2019, 37: 130-130. DOI: 10.1200/jco.2019.37.27_suppl.130.Peer-Reviewed Original ResearchMedication useEoL-1Medication receiptPoor patient-provider communicationAdvanced lung cancerHigh symptom burdenPatient demographic characteristicsPatient-provider communicationAge 77 yearsMedicare/MedicaidRace/ethnicity groupsNon-Hispanic whitesNausea/ vomitingSymptom burdenHospice enrollmentSymptom reliefConcurrent radiationSEER-MedicareOutpatient settingParenteral medicationsLung cancerMedicare beneficiariesPatientsLogistic regressionOlder adults